Trembizki E

Jennison AV

Buckley C

Bright A

Holds J

Ward A

Pitt J

Pendle S

Baird RW

Freeman K

Robson J

Mhango L

Lowry K

Lahra M

Whiley D

2020-10-06

The University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia.

Public Health Microbiology, Forensic and Scientific Services, Health Support Queensland, Brisbane, Queensland, Australia.

Office of Health Protection, Australian Government Department of Health, ACT, Australia.

South Australia Pathology, Adelaide, South Australia, Australia.

Adelaide Sexual Health Centre, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

Adelaide City General Practice, South Australia, Australia.

Australian Clinical Labs, Bella Vista, New South Wales, Australia.

Royal Darwin Hospital, Darwin, Territory Pathology, Northern Territory, Australia.

Sullivan Nicolaides Pathology, Queensland, Australia.

World Health Organization Collaborating Centre for STI and AMR, Sydney, New South Wales, Australia.

University of New South Wales, Sydney, Australia.

Pathology Queensland Central Laboratory, Brisbane, Australia.

J Antimicrob Chemother. 2020 Oct 6:dkaa402. doi: 10.1093/jac/dkaa402.

https://pubmed.ncbi.nlm.nih.gov/33020835/?otool=iaurydwlib

https://hdl.handle.net/10137/11436

Enhanced molecular surveillance in response to the detection of extensively resistant gonorrhoea in Australia.

Journal Article

Publication